Which biologics work for pustular psoriasis?
Systematic review pulls together the sparse evidence on the topic
Infliximab is the first-line agent of choice for pustular psoriasis, dermatologists suggest, but ustekinumab is a good alternative.
Researchers conducted a systematic review analysing data from about 40 articles, published between 2012 and 2018, on biologic therapies used to manage the rare but potentially life-threatening disease.
